These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 4655109

  • 21. Corticosteroid bioavailability assays. Correlation with a clinical study.
    Burdick KH.
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):19-23. PubMed ID: 5291630
    [No Abstract] [Full Text] [Related]

  • 22. [Effects and side effects of corticosteroids in allotransplantation].
    Klaue P.
    Fortschr Med; 1976 Mar 18; 94(9):491-500. PubMed ID: 786840
    [Abstract] [Full Text] [Related]

  • 23. Depigmenting action of corticosteroids. Experimental study on guinea pigs.
    Arnold J, Anthonioz P, Marchand JP.
    Dermatologica; 1975 Mar 18; 151(5):274-80. PubMed ID: 1225665
    [Abstract] [Full Text] [Related]

  • 24. [Local dermatological therapy with corticosteroids].
    Wereide K.
    Tidsskr Nor Laegeforen; 1970 Sep 01; 90(17):1633-4. PubMed ID: 5456623
    [No Abstract] [Full Text] [Related]

  • 25. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB.
    Arch Dermatol; 1972 Dec 01; 106(6):825-7. PubMed ID: 4639246
    [No Abstract] [Full Text] [Related]

  • 26. [Optimal measurement technic for the vasoconstrictor effect of corticosteroids. Comparative studies with reflection photometry and flow measurement].
    Gloor M, Sprenger HJ, Priebe L.
    Dermatol Monatsschr; 1979 Sep 01; 165(9):665-9. PubMed ID: 527746
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Side effects and complications of the local corticosteroid therapy of dermatoses].
    Ivanov NA.
    Vestn Dermatol Venerol; 1978 Oct 01; (10):27-31. PubMed ID: 706729
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids.
    Evans DP, Hossack M, Thomson DS.
    Br J Pharmacol; 1971 Oct 01; 43(2):403-8. PubMed ID: 5158205
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Value of human pharmacology test methods in the comparative assessment of topical corticosteroids].
    Holzmann H, Lachner H.
    Arch Klin Exp Dermatol; 1969 Oct 01; 234(3):261-72. PubMed ID: 5810023
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Studies of the vasoconstrictive effect of steroid prepartions for external use by means of remitometric photoplethysmography].
    Rovenský J, Záhejský J.
    Cesk Dermatol; 1973 Dec 01; 48(6):361-6. PubMed ID: 4771778
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline].
    Brehm K, Maucher OM.
    Arzneimittelforschung; 1972 Jun 01; 22(6):1038-9. PubMed ID: 5068352
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.